Moderna Therapeutics is a biotechnology company that focuses on developing messenger RNA (mRNA) therapies to treat a wide range of diseases. The company was founded in 2010 and is headquartered in Cambridge, Massachusetts. Moderna's technology platform is based on the use of mRNA, a type of RNA that carries genetic information from DNA to the ribosome, where it is used to synthesize proteins. The company's mRNA therapies are designed to instruct cells in the body to produce specific proteins that can help to prevent or treat a variety of diseases, including cancer, infectious diseases, and rare genetic disorders. Moderna has a strong pipeline of clinical and preclinical candidates and has received significant funding from investors such as AstraZeneca, Merck, and Vertex Pharmaceuticals.